JP2017532965A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017532965A5 JP2017532965A5 JP2017520926A JP2017520926A JP2017532965A5 JP 2017532965 A5 JP2017532965 A5 JP 2017532965A5 JP 2017520926 A JP2017520926 A JP 2017520926A JP 2017520926 A JP2017520926 A JP 2017520926A JP 2017532965 A5 JP2017532965 A5 JP 2017532965A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- peptide
- seq
- acid residues
- angiogenic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1418562.3A GB201418562D0 (en) | 2014-10-20 | 2014-10-20 | Peptides |
| GB1418562.3 | 2014-10-20 | ||
| PCT/GB2015/053130 WO2016063042A1 (en) | 2014-10-20 | 2015-10-20 | Fragments of syndecan-2 having anti-angiogenic activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017532965A JP2017532965A (ja) | 2017-11-09 |
| JP2017532965A5 true JP2017532965A5 (enExample) | 2018-11-22 |
| JP6725940B2 JP6725940B2 (ja) | 2020-07-22 |
Family
ID=52013244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017520926A Active JP6725940B2 (ja) | 2014-10-20 | 2015-10-20 | 抗血管新生活性を有するシンデカン−２のフラグメント |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US10766942B2 (enExample) |
| EP (1) | EP3209683A1 (enExample) |
| JP (1) | JP6725940B2 (enExample) |
| GB (1) | GB201418562D0 (enExample) |
| WO (1) | WO2016063042A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130213393A1 (en) | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
| GB201202319D0 (en) | 2012-02-10 | 2012-03-28 | Orbsen Therapeutics Ltd | Stromal stem cells |
| AU2014255755B2 (en) | 2013-04-16 | 2018-10-25 | Orbsen Therapeutics Limited | Medical use of syndecan-2 |
| US10124038B2 (en) | 2015-03-20 | 2018-11-13 | Orbsen Therapeutics Limited | Modulators of syndecan-2 and uses thereof |
| US11918687B2 (en) | 2016-01-15 | 2024-03-05 | Orbsen Therapeutics Limited | SDC-2 exosome compositions and methods of isolation and use |
| WO2018112061A1 (en) | 2016-12-15 | 2018-06-21 | Evoke Pharma, Inc. | Treatment of moderate and severe gastroparesis |
| KR102722188B1 (ko) | 2017-07-14 | 2024-10-24 | 오르브센 테라퓨틱스 리미티드 | 씨디39 기질 줄기세포 단리 방법 및 용도 |
| WO2019232203A2 (en) * | 2018-05-31 | 2019-12-05 | Yale University | Methods and compositions to alleviate vascular permeability |
| WO2022179518A1 (en) * | 2021-02-25 | 2022-09-01 | Rosas Ivan O | Anti-fibrotic peptides and uses thereof |
| GB202110693D0 (en) | 2021-07-26 | 2021-09-08 | Univ London Queen Mary | Peptides |
| IT202100023357A1 (it) | 2021-09-09 | 2023-03-09 | Cheirontech S R L | Peptidi con attività anti-angiogenica |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486599A (en) * | 1989-03-29 | 1996-01-23 | The Board Of Trustees Of The Leland Stanford Junior University | Construction and use of synthetic constructs encoding syndecan |
| US20040142325A1 (en) * | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US20050037962A1 (en) * | 2002-01-18 | 2005-02-17 | Ekker Stephen C. | Syndecans and angiogenesis |
| US20070054332A1 (en) | 2005-08-10 | 2007-03-08 | Alan Rapraeger | Syndecan 1 ectodomain inhibits cancer |
| US20080020979A1 (en) * | 2006-06-09 | 2008-01-24 | Rapraeger Alan C | Peptides of Syndecan-1 For Inhibiting Angiogenesis |
| AU2014251388B2 (en) * | 2013-04-12 | 2017-03-30 | Evox Therapeutics Limited | Therapeutic delivery vesicles |
-
2014
- 2014-10-20 GB GBGB1418562.3A patent/GB201418562D0/en not_active Ceased
-
2015
- 2015-10-20 WO PCT/GB2015/053130 patent/WO2016063042A1/en not_active Ceased
- 2015-10-20 JP JP2017520926A patent/JP6725940B2/ja active Active
- 2015-10-20 US US15/520,149 patent/US10766942B2/en active Active
- 2015-10-20 EP EP15785176.7A patent/EP3209683A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017532965A5 (enExample) | ||
| JP2016509011A5 (enExample) | ||
| JP6910408B2 (ja) | アネキシンｖの製造プロセス | |
| PH12020550706A1 (en) | Adeno-associated virus variant capsids and use for inhibiting angiogenesis | |
| IL288541B (en) | Vaccine against rsv | |
| PH12018502387A1 (en) | Adeno-associated virus variant capsids and methods of use thereof | |
| JP2014110810A5 (enExample) | ||
| JP2016516068A5 (enExample) | ||
| JP2011087580A5 (enExample) | ||
| JP2016506416A5 (enExample) | ||
| IL253187B (en) | Novel multivalent nanoparticle-based vaccines | |
| JP2013543499A5 (enExample) | ||
| JP2017532343A5 (enExample) | ||
| JP2012115277A5 (enExample) | ||
| JP2019513752A5 (enExample) | ||
| JP2020518287A5 (enExample) | ||
| HRP20251312T1 (hr) | Poboljšana protutijela za il-6 | |
| JP2019520405A5 (enExample) | ||
| JP2019535651A5 (enExample) | ||
| JP2013518037A5 (enExample) | ||
| JP2017505624A5 (enExample) | ||
| JP2015517484A5 (enExample) | ||
| JP2019528739A5 (enExample) | ||
| PE20210918A1 (es) | Composiciones y metodos para el tratamiento de la distrofia macular | |
| WO2020152318A3 (en) | High growth influenza virus |